HCPCS codes

22721 HCPCS codes with hospital pricing data in the network.

• HCPCS J1306 — Inclisiran injection, per 1 mgAI (1702 hospitals, 29,260–30,934 samples)
• HCPCS J9380 — Teclistamab injection, per 0.5 mgAI (1448 hospitals, 30,337–30,814 samples)
• HCPCS J2800 — Methocarbamol injection, muscle relaxantAI (1907 hospitals, 19,692–30,582 samples)
• HCPCS Q9968 — Indocyanine green injection, 25 mgAI (2175 hospitals, 16,181–29,861 samples)
• HCPCS J3411 — Thiamine hydrochloride injection, 100 mg/mLAI (2376 hospitals, 10,564–29,734 samples)
• HCPCS J3375 — Vancomycin hydrochloride injection, 10 mgAI (1094 hospitals, 24,796–29,449 samples)
• HCPCS J7799 — Unspecified drug given through medical equipmentAI (563 hospitals, 28,451–29,387 samples)
• HCPCS C1764 — Loop recorder confirmation (prescription)AI (1831 hospitals, 3,968–29,339 samples)
• HCPCS G0283 — Unattended electrical stimulation therapyAI (1998 hospitals, 21,985–29,320 samples)
• HCPCS J2590 — Oxytocin injection, 10 units per mLAI (2213 hospitals, 19,263–29,145 samples)
• HCPCS J0561 — Penicillin G benzathine injectionAI (2376 hospitals, 6,124–28,813 samples)
• HCPCS A9541 — Technetium-99m sulfur colloid radioactive tracerAI (2175 hospitals, 7,537–28,579 samples)
• HCPCS Q5117 — Trastuzumab-anns (Kanjinti) biosimilar injection, 10 mgAI (1734 hospitals, 25,740–28,260 samples)
• HCPCS C1883 — Deep brain stimulation lead extension, 60 cmAI (1751 hospitals, 3,263–28,139 samples)
• HCPCS J0165 — Epinephrine prefilled syringe for IV injectionAI (1630 hospitals, 16,241–27,995 samples)
• HCPCS J0688 — Cefazolin 3 g injectionAI (1651 hospitals, 17,795–27,803 samples)
• HCPCS A9513 — Lutetium-177 dotatate radiopharmaceutical, 1 millicurieAI (1353 hospitals, 27,021–27,678 samples)
• HCPCS J1299 — Eculizumab injection, per 2 mgAI (1460 hospitals, 26,977–27,517 samples)
• HCPCS J9312 — Rituximab injection, per 10 mgAI (2082 hospitals, 25,173–27,279 samples)
• HCPCS J1790 — Droperidol injectionAI (2146 hospitals, 14,074–26,566 samples)
• HCPCS J2323 — Injection of natalizumab, per milligramAI (1816 hospitals, 25,041–26,472 samples)
• HCPCS V5257 — Digital behind-the-ear hearing aid, monauralAI (487 hospitals, 2,763–26,334 samples)
• HCPCS A9517 — Iodine-131 sodium iodide oral capsule therapyAI (1879 hospitals, 21,838–26,293 samples)
• HCPCS G0472 — Hepatitis C antibody screening for high-risk patientsAI (1482 hospitals, 21,537–26,109 samples)
• HCPCS C1897 — Spinal cord stimulator trial kit with cableAI (1736 hospitals, 2,648–26,075 samples)
• HCPCS Q9969 — Technetium-99m radioactive tracer dose add-onAI (1056 hospitals, 21,683–25,913 samples)
• HCPCS A9595 — Piflufolastat F-18 diagnostic imaging agent, per millicurieAI (1469 hospitals, 23,345–25,685 samples)
• HCPCS G0379 — Hospital observation stay after direct referralAI (2260 hospitals, 9,900–25,668 samples)
• HCPCS G0260 — Sacroiliac joint injection with imaging guidanceAI (1913 hospitals, 10,072–25,435 samples)
• HCPCS S5010 — Dextrose 5% and half-normal saline IV solution, 1000 mLAI (903 hospitals, 25,038–25,380 samples)
• HCPCS A9502 — Technetium-99m tetrofosmin imaging agentAI (1814 hospitals, 14,955–25,242 samples)
• HCPCS C8908 — Breast MRI without, then with contrast, both sidesAI (1763 hospitals, 14,711–25,142 samples)
• HCPCS A0425 — Ground ambulance mileage, per statute mileAI (882 hospitals, 20,944–24,904 samples)
• HCPCS J9228 — Ipilimumab injection, per 1 mgAI (1882 hospitals, 22,869–24,714 samples)
• HCPCS J9260 — Methotrexate injection, 50 mgAI (2181 hospitals, 9,834–24,459 samples)
• HCPCS J2274 — Injectable morphine, preservative-freeAI (2138 hospitals, 15,396–24,243 samples)
• HCPCS G0399 — Home sleep apnea test with portable monitorAI (1682 hospitals, 16,294–23,863 samples)
• HCPCS A9537 — Technetium-99m mebrofenin diagnostic imaging agentAI (2124 hospitals, 8,299–23,851 samples)
• HCPCS J7613 — Albuterol sulfate nebulizer solution 2.5 mgAI (1625 hospitals, 8,567–23,804 samples)
• HCPCS Q9965 — Low-osmolar contrast dye, 100-199 iodine, per mLAI (1642 hospitals, 18,318–23,637 samples)
• HCPCS C2628 — Eclipse balloon catheterAI (1785 hospitals, 3,202–23,506 samples)
• HCPCS C1782 — Surgical morcellator device for tissue removalAI (1271 hospitals, 4,969–23,149 samples)
• HCPCS J8501 — Oral aprepitant 5 mgAI (1715 hospitals, 12,204–23,094 samples)
• HCPCS J1602 — Golimumab IV injection, per milligramAI (1875 hospitals, 21,747–22,989 samples)
• HCPCS L3260 — Cast boot, large unisex, 11.5 inchesAI (1340 hospitals, 2,475–22,914 samples)
• HCPCS H2035 — Alcohol and drug treatment program, per hourAI (281 hospitals, 2,870–22,760 samples)
• HCPCS J7620 — Ipratropium-albuterol nebulizer solution, 0.5-2.5 mg per 3 mLAI (1586 hospitals, 9,547–22,579 samples)
• HCPCS C9600 — Drug-eluting coronary stent placement, single arteryAI (1946 hospitals, 8,638–22,462 samples)
• HCPCS J9041 — Bortezomib cancer drug injectionAI (2072 hospitals, 18,709–22,210 samples)
• HCPCS G0422 — Intensive cardiac rehabilitation session with monitoringAI (1157 hospitals, 21,503–22,196 samples)